Development and clinical validation of a novel algorithmic score (GAAD) for detecting HCC in prospective cohort studies

内科学 医学 前瞻性队列研究 队列 肿瘤科 计算机科学
作者
Teerha Piratvisuth,Jinlin Hou,Tawesak Tanwandee,Thomas Berg,Arndt Vogel,Jörg Trojan,Enrico N. De Toni,Masatoshi Kudo,Anja Eiblmaier,Hanns‐Georg Klein,Johannes Kolja Hegel,Kairat Madin,Konstantin Kroeniger,Ashish Sharma,Henry Lik‐Yuen Chan
出处
期刊:Hepatology communications [Lippincott Williams & Wilkins]
卷期号:7 (11) 被引量:18
标识
DOI:10.1097/hc9.0000000000000317
摘要

Background: Alpha-fetoprotein (AFP) and des-gamma carboxyprothrombin (DCP), also known as protein induced by vitamin K absence-II (PIVKA-II [DCP]) are biomarkers for HCC with limited diagnostic value when used in isolation. The novel GAAD algorithm is an in vitro diagnostic combining PIVKA-II (DCP) and AFP measurements, age, and gender (biological sex) to generate a semi-quantitative result. We conducted prospective studies to develop, implement, and clinically validate the GAAD algorithm for differentiating HCC (early and all-stage) and benign chronic liver disease (CLD), across disease stages and etiologies. Methods: Patients aged ≥18 years with HCC or CLD were prospectively enrolled internationally into algorithm development [n = 1084; 309 HCC cases (40.7% early-stage) and 736 controls] and clinical validation studies [n = 877; 366 HCC cases (47.6% early-stage) and 303 controls]. Serum samples were analyzed on a cobas ® e 601 analyzer. Performance was assessed using receiver operating characteristic curve analyses to calculate AUC. Results: For algorithm development, AUC for differentiation between early-stage HCC and CLD was 90.7%, 84.4%, and 77.2% for GAAD, AFP, and PIVKA-II, respectively. The sensitivity of GAAD for the detection of early-stage HCC was 71.8% with 90.0% specificity. Similar results were shown in the clinical validation study; AUC for differentiation between early-stage HCC and CLD was 91.4% with 70.1% sensitivity and 93.7% specificity. GAAD also showed strong specificity, with a lower rate of false positives regardless of disease stage, etiology, or region. Conclusions: The GAAD algorithm significantly improves early-stage HCC detection for patients with CLD undergoing HCC surveillance. Further phase III and IV studies are warranted to assess the utility of incorporating the algorithm into clinical practice.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
Firsterchao的应助被lufang采纳,获得10
1秒前
蜗牛完成签到,获得积分10
1秒前
violet完成签到,获得积分10
1秒前
柔弱的冰兰完成签到,获得积分20
2秒前
李健的应助被顺利的莺采纳,获得10
2秒前
YOUNG929的应助被快乐友儿采纳,获得10
3秒前
3秒前
Mr先生完成签到 ,获得积分10
3秒前
shelemi发布了新的文献求助10
3秒前
平淡荟完成签到,获得积分10
3秒前
洛神之心1124完成签到,获得积分10
3秒前
萤熵完成签到,获得积分10
3秒前
果酱的奥特曼完成签到,获得积分10
4秒前
张张完成签到,获得积分10
4秒前
glowe完成签到,获得积分10
4秒前
乐乐关注了科研通微信公众号
4秒前
东山小红完成签到,获得积分10
4秒前
沉静野狼完成签到,获得积分10
5秒前
橘子完成签到,获得积分10
5秒前
十一点睡觉完成签到,获得积分10
5秒前
5秒前
yyyyy完成签到,获得积分10
5秒前
6秒前
忧伤的静竹完成签到,获得积分10
7秒前
洛宁发布了新的文献求助10
7秒前
NiNi完成签到,获得积分10
7秒前
竞鹤完成签到,获得积分10
7秒前
7秒前
周末完成签到,获得积分10
7秒前
SciGPT的应助被奋斗世德采纳,获得10
7秒前
七安完成签到 ,获得积分10
8秒前
sssane发布了新的文献求助10
8秒前
科研通AI6.4的应助被呼呼哈哈采纳,获得10
8秒前
李爱国的应助被本末倒纸采纳,获得10
8秒前
9秒前
lufang完成签到,获得积分10
9秒前
ldy完成签到,获得积分10
9秒前
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180488
求助须知:如何正确求助?哪些是违规求助? 9570437
关于积分的说明 21812406
捐赠科研通 7776516
什么是DOI,文献DOI怎么找? 3433277
关于科研通互助平台的介绍 2557516
邀请新用户注册赠送积分活动 2479162